학술논문

The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance
Document Type
Journal
Source
BLOOD COAGULATION & FIBRINOLYSIS; APR 2001, 12 3, p179-p186, 8p.
Subject
Language
English
ISSN
09575235